Yiyun Li - DV Biomed Chief Operating Officer
| 6539 Stock | TWD 66.80 0.20 0.30% |
COO
Yiyun Li is Chief Operating Officer of DV Biomed Co since 2020.
| Tenure | 4 years |
| Phone | 886 2 2791 1826 |
| Web | http://www.dvbiomed.com |
DV Biomed Management Efficiency
The company has return on total asset (ROA) of 8.85 % which means that it generated a profit of $8.85 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 23.52 %, meaning that it generated $23.52 on every $100 dollars invested by stockholders. DV Biomed's management efficiency ratios could be used to measure how well DV Biomed manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | COO Age | ||
| HanChang Hsieh | Ambassador Hotel | N/A | |
Management Performance
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 |
DV Biomed Leadership Team
Elected by the shareholders, the DV Biomed's board of directors comprises two types of representatives: DV Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 6539. The board's role is to monitor DV Biomed's management team and ensure that shareholders' interests are well served. DV Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DV Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qunzhi Chen, Independent Director | ||
| Peter Hou, Independent Director | ||
| Xiumei Xie, Chief Financial Officer, Head of Finance | ||
| Liqi Zhang, Chairman of the Board, General Manager | ||
| RongChun Lin, Independent Director | ||
| Senxiong Zhang, Independent Director | ||
| Qingjun Huang, Deputy General Manager-Administration Division | ||
| Mingtong Chen, Director | ||
| Jiaqi Zhang, Director | ||
| Mingfeng He, Head of Finance & Accounting | ||
| Yiyun Li, Chief Operating Officer |
6539 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DV Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 | |||
| Profit Margin | 16.64 % | |||
| Operating Margin | 14.88 % | |||
| Current Valuation | 3.68 B | |||
| Shares Outstanding | 59.26 M | |||
| Price To Earning | 13.49 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 1.81 B |
Pair Trading with DV Biomed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.Moving together with 6539 Stock
Moving against 6539 Stock
| 0.67 | 2881B | Fubon Financial Holding | PairCorr |
| 0.66 | 9904 | Pou Chen Corp | PairCorr |
| 0.6 | 2881A | Fubon Financial Holding | PairCorr |
| 0.55 | 2882B | Cathay Financial Holding | PairCorr |
| 0.54 | 0057 | Fubon MSCI Taiwan | PairCorr |
The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.